Literature DB >> 10068680

Cyclin A1 expression in leukemia and normal hematopoietic cells.

R Yang1, T Nakamaki, M Lübbert, J Said, A Sakashita, B S Freyaldenhoven, S Spira, V Huynh, C Müller, H P Koeffler.   

Abstract

Human cyclin A1 is a newly cloned, tissue-specific cyclin that is prominently expressed in normal testis. In this study, we showed that cyclin A1 was highly expressed in a subset of leukemia samples from patients. The highest frequency of cyclin A1 overexpression was observed in acute myelocytic leukemias, especially those that were at the promyelocyte (M3) and myeloblast (M2) stages of development. Cyclin A1 expression was also detected in normal CD34(+) progenitor cells. The expression of cyclin A1 increased when these cells were stimulated to undergo myeloid differentiation in vitro. Taken together, our observations suggest that cyclin A1 may have a role in hematopoiesis. High levels of cyclin A1 expression are especially associated with certain leukemias blocked at the myeloblast and promyelocyte stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068680

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Correlation between cyclin A gene expression in adult patients with acute leukemia and drug resistance.

Authors:  Jie Ma; Shirong Xu; Yongrong Lai; Yuying Lu; Ergu Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

2.  The cyclin A1-CDK2 complex regulates DNA double-strand break repair.

Authors:  Carsten Müller-Tidow; Ping Ji; Sven Diederichs; Jenny Potratz; Nicole Bäumer; Gabriele Köhler; Thomas Cauvet; Chunaram Choudary; Tiffany van der Meer; Wan-Yu Iris Chan; Conrad Nieduszynski; William H Colledge; Mark Carrington; H Phillip Koeffler; Anja Restle; Lisa Wiesmüller; Joëlle Sobczak-Thépot; Wolfgang E Berdel; Hubert Serve
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

3.  Cyclin A1 regulates the interactions between mouse haematopoietic stem and progenitor cells and their niches.

Authors:  Regina Miftakhova; Andreas Hedblom; Leah Batkiewicz; Lola Anagnosaki; Yuan Zhang; Anita Sjölander; Anette Gjörloff Wingren; Debra J Wolgemuth; Jenny L Persson
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.

Authors:  Rui-Qing Tian; Xing-Hua Wang; Li-Juan Hou; Wei-Hua Jia; Qian Yang; Yi-Xuan Li; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

5.  Cyclin A1 is a transcriptional target of PITX2 and overexpressed in papillary thyroid carcinoma.

Authors:  Yan Liu; Yue Huang; Guo-Zhang Zhu
Journal:  Mol Cell Biochem       Date:  2013-09-04       Impact factor: 3.396

6.  The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2016-07-22

7.  Post-translational modification of cyclin A1 is associated with staurosporine and TNFalpha induced apoptosis in leukemic cells.

Authors:  Jenny Ekberg; Jenny Liao Persson
Journal:  Mol Cell Biochem       Date:  2008-09-12       Impact factor: 3.396

8.  The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

Authors:  Luke F Peterson; Ming Yan; Dong-Er Zhang
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

Review 9.  Involvement of cyclins in mammalian spermatogenesis.

Authors:  Qingsheng Yu; Ji Wu
Journal:  Mol Cell Biochem       Date:  2008-05-11       Impact factor: 3.396

10.  Anticancer activity of VDR-coregulator inhibitor PS121912.

Authors:  Preetpal S Sidhu; Kelly Teske; Belaynesh Feleke; Nina Y Yuan; Margaret L Guthrie; Grant B Fernstrum; Nishita D Vyas; Lanlan Han; Joshua Preston; Jonathan W Bogart; Nicholas R Silvaggi; James M Cook; Rakesh K Singh; Daniel D Bikle; Leggy A Arnold
Journal:  Cancer Chemother Pharmacol       Date:  2014-08-09       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.